People · Operator
Named in public records as an officer, director or promoter · active 2012–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hamilton Thorne Ltd. | — | Biotechnology | Series A | $11.5M | $5.4M | 2012 |
Dean H. Gendron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dean H. Gendron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert J. Potter | 1 | 3 |
| David Wolf | 1 | 3 |
| Daniel K. Thorne | 1 | 2 |
| Meg Spencer | 1 | 2 |
| Daniel H. Thorne | 1 | 1 |
| Bruno H. Maruzzo | 1 | 1 |
| David P. Sable | 1 | 1 |
| David H. Sable | 1 | 1 |
| Meg H. Spencer | 1 | 1 |
| Diarmaid H. Douglas-Hamilton | 1 | 1 |
| Robert H. Potter | 1 | 1 |
| Michael H. Bruns | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.